FY2025 · ended Dec 31, 2025 · Revenue $402.07B, +7.8% YoY · Filed Feb 10, 2026
CVS HEALTH Corp (CVS) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $402.1 billion and net income of $1.8 billion. Free cash flow was $7.8 billion. As of Sep 30, 2026 it held $49.0 billion in cash and investments and $71.8 billion in total debt.
Revenue (TTM)
$420.61B
+6.7% vs year-ago TTM
Net income (TTM)
$11.04B
+2253.3% vs year-ago TTM
Operating cash flow (TTM)
$18.71B
+105.4% vs year-ago TTM
Free cash flow (TTM)
$15.57B
+147.4% vs year-ago TTM
EPS (TTM)
$8.58
+2215.0% vs year-ago TTM
Dividend per share (TTM)
$2.66
+0.0% vs year-ago TTM
Shares outstanding
1.27B
+0.9% vs prior year
Net cash
$-22.89B
as of Sep 30, 2026
Operating margin
3.6%
FY 2026
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- CVS (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Woonsocket, RI
- SEC filer status
- Large accelerated filer
- SEC CIK
- 64803
- Former names
- CVS CAREMARK CORP (until Sep 3, 2014); CVS/CAREMARK CORP (until May 8, 2007); CVS CORP (until Mar 22, 2007); MELVILLE CORP (until Jan 10, 1997)
Other Retail-Drug Stores and Proprietary Stores companies
- Guardian Pharmacy Services, Inc. GRDN
- 111, Inc. YI
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | $292.1B |
| Operating income | $4.7B | $8.5B | $13.7B | $8.0B | $13.3B |
| Net income | $1.8B | $4.6B | $8.3B | $4.3B | $8.0B |
| Diluted EPS | $1.39 | $3.66 | $6.47 | $3.26 | $6.02 |
| Operating cash flow | $10.6B | $9.1B | $13.4B | $16.2B | $18.3B |
| Free cash flow | $7.8B | $6.3B | $10.4B | $13.4B | $15.7B |
| Total assets | $253.5B | $253.2B | $249.7B | $228.3B | $233.0B |
| Total liabilities | $178.2B | $177.5B | $173.1B | $156.5B | $157.6B |
| Stockholders' equity | $75.2B | $75.6B | $76.5B | $71.5B | $75.1B |
| Cash and investments | $43.3B | $39.9B | $34.5B | $36.8B | $35.5B |
| Total debt | $16.7B | $20.1B | $19.4B | $69.0B | $71.8B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 17, 2026 | Aug 13, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
All 1003 CVS HEALTH Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.